Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy

Genetic engineering has resulted in more than 50 recombinant bispecific antibody formats over the past two decades. Bispecific scFv antibodies represent a successful and promising immunotherapy platform that retargets cytotoxic T cells to tumor cells, with one scFv directed to tumor-associated antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shu-juan, Wei, Jia, Su, Shu, Chen, Fang-jun, Qiu, Yu-dong, Liu, Bao-rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688922/
https://www.ncbi.nlm.nih.gov/pubmed/29151956
http://dx.doi.org/10.7150/jca.19501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688922/
https://www.ncbi.nlm.nih.gov/pubmed/29151956
http://dx.doi.org/10.7150/jca.19501

Ejemplares similares